Article
A critical appraisal of the current landscape of resectable BRAF mutated colorectal liver metastases: a systematic review.
Chinese clinical oncology - 1 Aug 2024
Margonis Georgios Antonios, Wang Jaeyun, Papakonstantinou Dimitris, Beyer Katharina, Kreis Martin E, D'Angelica Michael
Abstract excerpt
BACKGROUND: Patients with surgically resectable BRAF-mutated colorectal liver metastases (CRLM) or limited extrahepatic disease constitute a highly selective subgroup among BRAF-mutated patients, characterized by a more indolent disease biology. This is evident in their suitability for surgical resection. However, initial studies from a decade ago presented a discouraging outlook for these patients, citing early,...
Topics
- Humans
- Colorectal Neoplasms
- Proto-Oncogene Proteins B-raf
- Liver Neoplasms
- Mutation
